(Q58024833)
Statements
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma (English)
Michael Millward
Paul Mainwaring
Ted Logan
Anna Pavlick
Ahmad A Tarhini
Steven J Kathman
Kevin H Laubscher
Mohammed M Dar
John M Kirkwood